Stockscreener 앱 받기
0.1816
3.35%
-0.0063
시간 외 거래:
.18
-0.0016
-0.88%
전일 마감가:
$0.1879
열려 있는:
$0.1868
하루 거래량:
121.76K
Relative Volume:
0.44
시가총액:
$1.35M
수익:
$3,000
순이익/손실:
$-5.65M
주가수익비율:
-0.145
EPS:
-1.2521
순현금흐름:
$-5.88M
1주 성능:
-7.35%
1개월 성능:
-19.29%
6개월 성능:
-71.10%
1년 성능:
-85.24%
1일 변동 폭
$0.18
$0.1959
1주일 범위
$0.18
$0.21
52주 변동 폭
$0.18
$1.35
Virax Biolabs Group Ltd Stock (VRAX) Company Profile
Compare VRAX vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
VRAX
Virax Biolabs Group Ltd
|
0.1816 | 1.39M | 3,000 | -5.65M | -5.88M | -1.2521 |
|
VRTX
Vertex Pharmaceuticals Inc
|
458.05 | 114.72B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
737.45 | 78.67B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
684.50 | 42.38B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
311.10 | 41.75B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
282.72 | 31.33B | 5.36B | 287.73M | 924.18M | 2.5229 |
Virax Biolabs Group Ltd Stock (VRAX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-03-31 | 개시 | H.C. Wainwright | Buy |
Virax Biolabs Group Ltd 주식(VRAX)의 최신 뉴스
Virax Biolabs Shareholders Approve Reverse Split, New Charter and 2026 Equity Plan After Adjourned AGM - TipRanks
Virax Biolabs (VRAX) backs reverse split range and 2M-share incentive plan - Stock Titan
Virax Biolabs (VRAX) CEO reports holdings in shares and options - Stock Titan
Virax Biolabs Group Ltd (VRAX) director discloses multiple option grants - Stock Titan
Virax Biolabs (VRAX) CFO Jason Davis becomes reporting insider with Form 3 - Stock Titan
Virax Biolabs (VRAX) director files initial insider ownership report - Stock Titan
Momentum Shift: What are Virax Biolabs Group Limiteds earnings expectations2026 Trading Recap & Fast Entry Momentum Trade Alerts - baoquankhu1.vn
00019 Should I Buy - Intellectia AI
PRH Should I Buy - Intellectia AI
AI Investing InsightsOfficial HomepageIntellectia AI™ - Intellectia AI
Virax Biolabs Group Limited (NASDAQ:VRAX) Short Interest Down 67.6% in February - Defense World
ONEG.O Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
MGR Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
US Market Recap: Will Virax Biolabs Group Limited benefit from sector rotationJuly 2025 Intraday Action & Community Shared Stock Ideas - baoquankhu1.vn
Volume Summary: How much upside does HSDT haveWeekly Market Outlook & Free Accurate Trade Setup Notifications - baoquankhu1.vn
TCGL Should I Buy - Intellectia AI
Day Trade: Is now the right time to enter AEISWeekly Trend Recap & Weekly Watchlist for Hot Stocks - baoquankhu1.vn
SKX PE Ratio & Valuation, Is SKX Overvalued - Intellectia AI
VRAX PE Ratio & Valuation, Is VRAX Overvalued - Intellectia AI
Analysts Offer Insights on Healthcare Companies: RegenXBio (RGNX) and Nektar Therapeutics (NKTR) - The Globe and Mail
IVF Should I Buy - Intellectia AI
Exit Recap: Is Oriental Culture Holding LTD stock risky to hold nowEarnings Summary Report & Short-Term High Return Ideas - baoquankhu1.vn
Virax Biolabs Sets March 11, 2026 AGM to Vote on Reverse Share Split and New Equity Plan - The Globe and Mail
Bull Bear: Does Virax Biolabs Group Limited offer margin of safetyMarket Activity Report & Safe Entry Momentum Stock Tips - baoquankhu1.vn
12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga
Exit Recap: Should I average down on PodcastOne Inc stockGap Down & Smart Investment Allocation Insights - baoquankhu1.vn
Virax Biolabs Group Limited (NASDAQ:VRAX) Short Interest Update - Defense World
12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga
Virax Biolabs Group (NASDAQ:VRAX) Upgraded at Zacks Research - Defense World
Virax Biolabs Group Limited (VRAX) Upgraded to Buy: Here's Why - Yahoo Finance
Virax Biolabs stock price target lowered to $1 at H.C. Wainwright By Investing.com - Investing.com South Africa
Virax Biolabs stock price target lowered to $1 at H.C. Wainwright - Investing.com India
Virax Biolabs secures $5 million in private placement to advance immunology research - MSN
HC Wainwright Reaffirms “Buy” Rating for Virax Biolabs Group (NASDAQ:VRAX) - Defense World
Virax Biolabs: Clinical Progress in PAIS and Extended Cash Runway Support Reiterated Buy Rating Despite Lowered Price Target - TipRanks
VRAX Analyst Forecasts - Quiver Quantitative
Why Virax Biolabs Group Limited stock is favored by top institutions - Улправда
12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga
Wondering what's happening in today's after-hours session? - Chartmill
Virax Biolabs Releases Interim Financial Results for September 2025 - The Globe and Mail
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
Is Virax Biolabs Group Limited stock positioned for long term growthJuly 2025 Update & Real-Time Market Trend Scan - Улправда
Can Virax Biolabs Group Limited stock beat market expectations this quarterWeekly Market Outlook & Real-Time Sentiment Analysis - Улправда
Virax Biolabs (NASDAQ: VRAX) details 25.9M-share resale from $5M raise - Stock Titan
Virax Biolabs Group (NASDAQ:VRAX) Shares Down 11.3% – Here’s Why - Defense World
A new trading data show Virax Biolabs Group Ltd (VRAX) is showing positive returns. - Setenews
12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga
Penny Stocks To Keep An Eye OnDecember 3rd - MarketBeat
Why Virax Biolabs Group Limited stock is seen as undervalued2025 Geopolitical Influence & Detailed Earnings Play Alerts - Newser
Virax Biolabs Secures $5 Million in Private Placement to Advance Immunology Research - The Globe and Mail
Virax Biolabs Group Ltd (VRAX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.20%
0.06%
자본화:
|
볼륨(24시간):